NCT05958303View on ClinicalTrials.gov

HYPEROXIA Responses and ROS

NACompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

July 24, 2024

Primary Completion Date

March 31, 2025

Study Completion Date

March 31, 2025

Conditions
Cerebrovascular Disorders
Interventions
DIETARY_SUPPLEMENT

Antioxidant Cocktail

Total dosing of 1000 mg vitamin C, 600 IU vitamin E, and 600 mg of alpha lipoic acid.

OTHER

Placebo

Placebo

Trial Locations (1)

53705

University of Wisconsin, Madison

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

University of Wisconsin, Madison

OTHER

NCT05958303 - HYPEROXIA Responses and ROS | Biotech Hunter | Biotech Hunter